Infective endocarditis in a Finnish teaching hospital: a study on 326 episodes treated during 1980-2004
- PMID: 16644858
- PMCID: PMC1861063
- DOI: 10.1136/hrt.2005.084715
Infective endocarditis in a Finnish teaching hospital: a study on 326 episodes treated during 1980-2004
Abstract
Objectives: To evaluate potential changes of infective endocarditis (IE) in patients treated in a Finnish teaching hospital during the past 25 years.
Patients: 326 episodes of IE in 303 patients treated during 1980-2004 were evaluated for clinical characteristics and their changes over time.
Results: The mean age of the patients increased with time (from 47.2 to 54.5 years, p = 0.003). Twenty-five (7.7%) episodes were associated with intravenous drug use (IVDU), with a significant increase of these episodes after 1996 (from 0 to 19 (20%), p < 0.001). Viridans streptococci were the most common causative agents of IE during 1980-1994, but after that Staphylococcus aureus was the most common pathogen (p = 0.015). The proportion of IE of the aortic valve decreased during the study (from 30 (49%) to 26 (27%), whereas the proportions of mitral (11 (18%) to 33 (35%) and tricuspid valve IE (0 to 13 (14%) increased correspondingly (p = 0.001). This was mainly due to more patients with IVDU. Chronic dialysis for renal failure as an underlying condition increased over time (from 0 to 7 (7.4%), p = 0.015) but no other predisposing conditions changed. Complications such as neurological manifestations and heart failure did not change in frequency, but the incidence of lung emboli increased (from 0% to 10.5%, p < 0.001); 83% of these emboli occurred in patients with IVDU. The proportion of patients requiring surgical treatment and mortality due to IE did not change.
Conclusions: During these 25 years, the causative agents, affected valves and complications of IE changed to some degree. These changes were mainly attributed to the increase of IVDU-associated IE. Except for the increase in age, the clinical presentation and outcome in non-addicts remained substantially unchanged.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
The changing face of infective endocarditis.Heart. 2006 Oct;92(10):1365-6. doi: 10.1136/hrt.2006.092635. Heart. 2006. PMID: 16973792 Free PMC article.
References
-
- Bayer A S. Infective endocarditis. Clin Infect Dis 199317313–322. - PubMed
-
- Moreillon P, Que Y ‐ A. Infective endocarditis. Lancet 2004363139–149. - PubMed
-
- Mylonakis E, Calderwood S B. Infective endocarditis in adults. N Engl J Med 20013451318–1330. - PubMed
-
- Garvey G J, Neu H C. Infective endocarditis: an evolving disease. Medicine 197857105–127. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous